Highest development stage: Phase 2

Development status: Inactive

Gram-negative activity

Mechanism of Action/Target pathogen: DNA gyrase inhibitor; Cell membrane inhibitor; effective against MRSA

Additional information: Arginine salt of the tricyclic fluoroquinolone <i>S</i>-(−)-nadifloxacin